Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H F Marlow

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
British Journal of Clinical Pharmacology|January 1, 1989
Xamoterol, a beta 1-adrenoceptor partial agonist: review of the clinical efficacy in heart failureH F Marlow
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|May 23, 1970
The pharmacological basis of drug dependenceH F Marlow
Circulation|February 1, 1990
Review of clinical experience with xamoterol. Effects on exercise capacity and symptoms in heart failureH F Marlow
Cardiology|January 1, 1994
Government intervention in cardiovascular disease--help or hindrance? The pharmaceutical industry viewpointH F Marlow
British Journal of Pharmacology|February 1, 1970
A model noradrenaline binding siteH F Marlow
Journal of Cardiovascular Pharmacology|January 1, 1989
The efficacy of xamoterol in heart failure of ischemic originH F Marlow
British Journal of Clinical Pharmacology|January 1, 1989
The effect of age and renal impairment on the pharmacokinetics of xamoterolW Bastain, H F Marlow
BMJ (Clinical Research Ed.)|December 7, 1996
Propranolol is contraindicated in asthmaJ M Fallowfield, H F Marlow
European Heart Journal|April 1, 1990
Xamoterol monotherapy in heart failure. The European 'Corwin' GroupR M Timewell, R D Stark, H F Marlow
British Journal of Clinical Pharmacology|April 1, 1979
The effects of time on the activity of beta-adrenoceptor blocking drugs [proceedings]J D Harry, H F Marlow, A G Shields
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
British Journal of Clinical Pharmacology|January 1, 1989
Xamoterol, a beta 1-adrenoceptor partial agonist: review of the clinical efficacy in heart failureH F Marlow
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|May 23, 1970
The pharmacological basis of drug dependenceH F Marlow
Circulation|February 1, 1990
Review of clinical experience with xamoterol. Effects on exercise capacity and symptoms in heart failureH F Marlow
Cardiology|January 1, 1994
Government intervention in cardiovascular disease--help or hindrance? The pharmaceutical industry viewpointH F Marlow
British Journal of Pharmacology|February 1, 1970
A model noradrenaline binding siteH F Marlow
Journal of Cardiovascular Pharmacology|January 1, 1989
The efficacy of xamoterol in heart failure of ischemic originH F Marlow
British Journal of Clinical Pharmacology|January 1, 1989
The effect of age and renal impairment on the pharmacokinetics of xamoterolW Bastain, H F Marlow
BMJ (Clinical Research Ed.)|December 7, 1996
Propranolol is contraindicated in asthmaJ M Fallowfield, H F Marlow
European Heart Journal|April 1, 1990
Xamoterol monotherapy in heart failure. The European 'Corwin' GroupR M Timewell, R D Stark, H F Marlow
British Journal of Clinical Pharmacology|April 1, 1979
The effects of time on the activity of beta-adrenoceptor blocking drugs [proceedings]J D Harry, H F Marlow, A G Shields
Pageof 2